LivaNova launches post-market study of bioprosthetic aortic heart valves

LivaNova (NSDQ:LIVN) announced today that the first patient has been enrolled in a post-market trial evaluating the overall incidence of reduced leaflet motion identified by CT imaging in patients receiving a bioprosthetic aortic heart valve. Four-dimensional CT scans will be taken of the trial’s 230 participants at least 30 days after they stop anticoagulation or dual antiplatelet therapy, according to LivaNova. The study will also include one year of follow-up. “Thrombus formation on valve leaflets has been shown to occur in some patients receiving prosthetic tissue valve replacement via transcatheter or open surgical procedures and may lead to leaflet thickening and immobility,” Brian Duncan, LivaNova’s VP of medical affairs in cardiac surgery, said in prepared remarks. “Believe is the first trial to examine this process with advanced imaging and a standardized approach to anticoagulation in patients undergoing implantation of LivaNova bioprosthetic aortic valves.” “The Believe study is designed to enhance the understanding of reduced leaflet motion phenomenon, while providing important information to clinicians and patients to ensure the best possible outcomes after surgical aortic valve replacement,” Dr. Basel Ramlawi, who enrolled the first patient in the trial and is the attending cardiothoracic surgeon and chairman of The Heart &Vascular Center at Valley Health System, added. London-based LivaNova also said toda...
Source: Mass Device - Category: Medical Devices Authors: Tags: Cardiovascular Clinical Trials Imaging Wall Street Beat LivaNova Source Type: news

Related Links:

Chem. Commun., 2018, Accepted Manuscript DOI: 10.1039/C8CC04241A, Communicationshern-long LEE, Kum-Yi Cheng, Chih-Hsun Lin, Mei-Chun Tzeng, Ayyaz Mahmood, Muhamma Saeed, Chun-Hsien Chen, Chi Wi Ong In this work, we studied a discotic liquid crystalline (DLC) of dibenzo[a,c]phenazine at the liquid-solid interface using scanning tunnelling microscopy/spectroscopy, by which we show how to tailor the DLC assemblies... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Chem. Commun. latest articles - Category: Chemistry Authors: Source Type: research
DIABETES type 2 symptoms are not always obvious, but it ’s important to recognise all the signs or do what you can to prevent the condition as it can lead to more serious health problems such as heart disease and stroke. If symptoms do show one in particular is linked to your toilet habits.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
PHILADELPHIA - Artificial intelligence (AI) software can accurately predict...Read more on AuntMinnie.comRelated Reading: How should AI be used in breast ultrasound? AI algorithm registers MRI scans in under 1 second SIIM: AI can accurately detect cerebral microbleeds Can AI reliably measure carotid intima-media thickness? AI can detect, assess white-matter lesions on CT scans
Source: Headlines - Category: Radiology Source Type: news
Kathryn C. Collins, Niamh C. Kennedy, Allan Clark, Valerie M. Pomeroy
Source: Frontiers in Neurology - Category: Neurology Source Type: research
AbstractThe aim of the present study was to determine whether circulating soluble CD23 (sCD23) was associated with B cells non-Hodgkin ’s lymphomas (B-NHL). PubMed, EMBASE, and ISI Web of Science were extensively searched without language restriction. Data was extracted in a standardized data collection sheet after two reviewers scanned studies independently. The association between sCD23 and NHL was indicated as odds ratio (OR) along with its related 95% confidence interval (95% CI). Meta-analysis was conducted via RevMan 5.3. A total of five studies, which included 964 B-NHL patients and 1243 matched controls witho...
Source: Annals of Hematology - Category: Hematology Source Type: research
Abstract Speech-language pathologists play a crucial role in the assessment and treatment of individuals with primary progressive aphasia (PPA). The speech-language evaluation is a critical aspect of the diagnostic and rehabilitative process, informing differential diagnosis as well as intervention planning and monitoring of cognitive-linguistic status over time. The evaluation should include a thorough case history and interview and a detailed assessment of speech-language and cognitive functions, with tasks designed to detect core and associated deficits outlined in current diagnostic criteria. In this paper, we...
Source: Seminars in Speech and Language - Category: Speech-Language Pathology Authors: Tags: Semin Speech Lang Source Type: research
Authors: Robson A, Sturman J, Williamson P, Conboy P, Penney S, Wood H Abstract This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. This paper provides recommendations on the pre-treatment clinical assessment of patients presenting with head and neck cancer. Recommendations • Comorbidity data should be collected as it is important in the analysis of survival, quality of life and functional outcomes after treatment as well as for comparing results of different treatment regimens and different centres. (R) • Patients with hyp...
Source: Journal of Laryngology and Otology - Category: ENT & OMF Tags: J Laryngol Otol Source Type: research
In this study, cangrelor was discontinued 1-6 hours prior to surgery, while aspirin was continued throughout the perioperative period. Bridging with cangrelor did not increase major bleeds prior to surgery, though minor bleeds, mostly ecchymosis at venipuncture site, was higher. P2Y12 assay documented sufficient platelet inhibition corresponding to levels required for anti thrombotic effect [1]. Cangrelor is awaiting approval and more large scale trials regarding the use of bridging are needed. Reference 1. Angiolillo DJ et al; BRIDGE Investigators. Bridging antiplatelet therapy with cangrelor in patients undergoing ...
Source: Cardiophile MD - Category: Cardiology Authors: Tags: Cardiology MCQ DM / DNB Cardiology Entrance Source Type: blogs
Conclusion The JenaValve transapical TAVI system is a safe and feasible procedure with low peri- and postoperative complications and convincing midterm performance of the prosthesis. PMID: 26030120 [PubMed - as supplied by publisher]
Source: The Thoracic and Cardiovascular Surgeon - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Thorac Cardiovasc Surg Source Type: research
Conclusion The JenaValve transapical TAVI system is a safe and feasible procedure with low peri- and postoperative complications and convincing midterm performance of the prosthesis.[...]Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals:Table of contents  |  Abstract  |  Full text
Source: The Thoracic and Cardiovascular Surgeon - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Original Cardiovascular Source Type: research
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Clinical Trials | CT Scan | Heart | Heart Attack | Heart Valve Disease | Heart Valve Surgery | Heart Valves | PET Scan | Stroke | Study | Thrombosis